Abbott Can't Wipe Out $2.2M Verdict In Humira Case

Law360, Chicago (August 22, 2013, 7:51 PM EDT) -- Abbott Laboratories and AbbVie Inc. lost a bid Wednesday to squelch an Illinois jury's $2.2 million verdict in favor of a man whose wife allegedly suffered a life-threatening fungal infection as a result of taking the blockbuster arthritis drug Humira.

Judge William Haddad of the Cook County Circuit Court denied the drugmakers' motion to set aside the verdict for a new trial, rejecting their argument that the jury's answer to a special interrogatory contradicted the verdict.

Plaintiff Milton Tietz alleged his wife's use of Humira nearly...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.